SANDRENA estradiol 0.1% gel 1g sachets Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

sandrena estradiol 0.1% gel 1g sachets

orion pharma (aus) pty limited - estradiol, quantity: 1 mg/g - gel - excipient ingredients: purified water; propylene glycol; carbomer 934p; ethanol; trolamine - short-term treatment of climacteric symptoms after natural or surgical menopause. whenever possible the lowest effective dose should be used. review the need for continuation of treatment after 6 months, taking into account the risk-benefit ratio for the individual user at that moment (including cardiovascular disease and breast cancer, see section 5.1 pharmacodynamic properties - clinical trials and section 4.4 special warnings and precautions for use). sandrena should only be continued for as long as the benefit outweighs the risks

SANDRENA estradiol 0.1% gel 0.5g sachets Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

sandrena estradiol 0.1% gel 0.5g sachets

orion pharma (aus) pty limited - estradiol, quantity: 1 mg/g - gel - excipient ingredients: trolamine; propylene glycol; ethanol; purified water; carbomer 934p - short-term treatment of climacteric symptoms after natural or surgical menopause. whenever possible the lowest effective dose should be used. review the need for continuation of treatment after 6 months, taking into account the risk-benefit ratio for the individual user at that moment (including cardiovascular disease and breast cancer, see section 5.1 pharmacodynamic properties - clinical trials and section 4.4 special warnings and precautions for use). sandrena should only be continued for as long as the benefit outweighs the risks.

Sandrena Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

sandrena

orion pharma (nz) limited - estradiol 1 mg/g;  ;   - transdermal gel - 0.1 % - active: estradiol 1 mg/g     excipient: carbomer ethanol propylene glycol purified water sodium hydroxide